Related Experiment Video
Updated: Aug 8, 2026

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva
Published on: May 16, 2012
Correlation between saliva and serum for human immunodeficiency virus 1 and 2 antibodies using a rapid test system
Insights
A new prototype OraScreen saliva dipstick offers a promising alternative to traditional blood-based human immunodeficiency virus (HIV) testing. This saliva test demonstrated high specificity and sensitivity, suggesting potential for convenient HIV screening.
Area of Science:
- * Virology and Infectious Diseases
- * Diagnostic Test Development
- * Public Health Screening
Background:
- * Current human immunodeficiency virus (HIV) diagnostics predominantly rely on serum (blood) analysis.
- * Venepuncture for blood collection can be challenging in certain clinical or field settings.
- * Developing alternative, non-invasive diagnostic methods for HIV is a significant public health goal.
Purpose of the Study:
- * To evaluate the diagnostic performance of a prototype OraScreen saliva dipstick for human immunodeficiency virus (HIV) detection.
- * To compare the accuracy of the saliva-based test against established serum-based diagnostic assays.
- * To assess the feasibility of using saliva as a viable sample type for HIV testing.
Main Methods:
- * The prototype OraScreen saliva dipsticks were tested on 278 samples.
- * Samples included individuals with confirmed HIV, attendees of a sexually transmitted disease clinic, and healthy controls.
- * Saliva test results were compared with serum-based enzyme-linked immunosorbent assay (ELISA) and Western blot tests.
Main Results:
- * The OraScreen saliva test achieved a specificity of 99.5% and a sensitivity of 94.7%.
- * These results indicate a high degree of accuracy in identifying individuals with and without HIV.
- * The test performed comparably to standard serum-based diagnostic methods.
Conclusions:
- * The prototype OraScreen dipstick demonstrates significant potential as a reliable method for saliva-based HIV testing.
- * Saliva testing offers a convenient alternative to blood collection, particularly in resource-limited or inconvenient settings.
- * Further large-scale studies in low-prevalence populations are warranted to fully validate saliva testing for HIV.
Abstract:
Currently, human immunodeficiency virus (HIV) tests are almost totally serum based. In situations where blood is difficult or inconvenient to obtain, a substitute to venepuncture offers an attractive alternative. The prototype OraScreen saliva dipsticks were tested on 278 samples comprising 100 normals, 100 samples from persons attending a sexually transmitted disease clinic and 78 samples from persons confirmed to have HIV. The specificity and the sensitivity of the diagnostic test for saliva was 99.5% and 94.7% respectively, when compared to a routine solid-phase enzyme-linked immunosorbent assay (ELISA) test on serum samples and Western blot test when indicated. The prototype OraScreen dipstick test shows potential for saliva testing in situations where it would be inconvenient to use blood. Further evaluation of saliva testing is warranted on a large sample population with a low prevalence of HIV infection.

